{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:12:01Z","timestamp":1782817921329,"version":"3.54.5"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"Supplement_D","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Atrial tachyarrhythmias and worsening heart failure frequently coexist and potentially progress to a life threatening condition. Therapeutic approach requires simultaneous management of rapid ventricular response and heart failure symptom relief in order to improve haemodynamic stability and cardiac function. Landiolol is an ultra-short-acting b-adrenergic receptor blocker with high b1 selectivity incorporated in 2020 European Society of Cardiology guidelines for the management of atrial fibrillation. We provide a report of two cases with atrial fibrillation treated with landiolol in the acute setting of pulmonary oedema and cardiogenic shock, respectively. Additionally, we searched the international database PUBMED (MEDLINE, PubMed Central) to retrieve scientific evidence regarding its implementation in the treatment of atrial tachyarrhythmias in patients with cardiac dysfunction. Recent studies support the use of landiolol in patients with acute heart failure and atrial tachyarrhythmias. Compared to digoxin, landiolol proved to be more effective in controlling heart rate, with minimal adverse effects. Moreover, landiolol may be helpful in the conversion of atrial tachyarrhythmia to sinus rhythm. A more potent effect has been reported in patients with heart failure with preserved or mildly reduced ejection fraction, small left ventricular volume and high blood pressure. Likewise, administration of low doses of landiolol in patients with cardiogenic shock and atrial tachyarrhythmias reduced heart rate and pulmonary capillary wedge pressure and improved cardiac contractility without reducing blood pressure. Landiolol seems to be an attractive alternative in the acute management of patients with atrial tachyarrhythmias and cardiac dysfunction, though further clinical trials are needed to establish its role.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suac024","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T11:33:44Z","timestamp":1648640024000},"page":"D22-D33","source":"Crossref","is-referenced-by-count":15,"title":["The role of landiolol in the management of atrial tachyarrhythmias in patients with acute heart failure and cardiogenic shock: case reports and review of literature"],"prefix":"10.1093","volume":"24","author":[{"given":"Sofia","family":"Bezati","sequence":"first","affiliation":[{"name":"Emergency Medicine Department, Attikon University Hospital , Rimini 1, Chaidari 12462, Athens , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Velliou","sequence":"additional","affiliation":[{"name":"Emergency Medicine Department, Attikon University Hospital , Rimini 1, Chaidari 12462, Athens , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eftihia","family":"Polyzogopoulou","sequence":"additional","affiliation":[{"name":"Emergency Medicine Department, Attikon University Hospital , Rimini 1, Chaidari 12462, Athens , Greece"},{"name":"Medical School, National and Kapodistrian University of Athens , Chaidari 12462, Athens , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Boultadakis","sequence":"additional","affiliation":[{"name":"Emergency Medicine Department, Attikon University Hospital , Rimini 1, Chaidari 12462, Athens , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Parissis","sequence":"additional","affiliation":[{"name":"Emergency Medicine Department, Attikon University Hospital , Rimini 1, Chaidari 12462, Athens , Greece"},{"name":"Medical School, National and Kapodistrian University of Athens , Chaidari 12462, Athens , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"2022061314501947100_suac024-B1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"2022061314501947100_suac024-B2","first-page":"32","article-title":"Effect of nesiritide in patients with acute decompensated heart failure [published correction appears in N Engl J Med. 2011 Aug 25; 365(8):773. Wilson, W H [corrected to Tang, W H W]]","volume":"365","author":"O\u2019Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"2022061314501947100_suac024-B3","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ejhf.890","article-title":"Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2022061314501947100_suac024-B4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/CIRCHEARTFAILURE.111.965681","article-title":"Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure","volume":"5","author":"Mountantonakis","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2022061314501947100_suac024-B5","doi-asserted-by":"crossref","first-page":"e002092","DOI":"10.1161\/JAHA.115.002092","article-title":"Acute heart failure and atrial fibrillation: insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) trial","volume":"4","author":"Abualnaja","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2022061314501947100_suac024-B6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrcardio.2015.191","article-title":"Comorbidity of atrial fibrillation and heart failure","volume":"13","author":"Ling","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"2022061314501947100_suac024-B7","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"2022061314501947100_suac024-B8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00392-017-1175-1","article-title":"Prognostic impact of atrial fibrillation in cardiogenic shock complicating acute myocardial infarction: a substudy of the IABP-SHOCK II trial","volume":"107","author":"de Waha","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"2022061314501947100_suac024-B9","doi-asserted-by":"crossref","first-page":"e007661","DOI":"10.1161\/CIRCINTERVENTIONS.118.007661","article-title":"Prognostic impact of atrial fibrillation in acute myocardial infarction and cardiogenic shock","volume":"12","author":"Feistritzer","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"2022061314501947100_suac024-B10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00392-017-1192-0","article-title":"Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI registry","volume":"107","author":"Backhaus","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"2022061314501947100_suac024-B11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jchf.2019.03.005","article-title":"Heart failure and atrial fibrillation, like fire and fury","volume":"7","author":"Carlisle","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2022061314501947100_suac024-B12","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [published correction appears in Eur Heart J. 2021 Oct 14]","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2022061314501947100_suac024-B13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2022061314501947100_suac024-B14","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1253\/circj.CJ-12-1618","article-title":"Urgent management of rapid heart rate in patients with atrial fibrillation\/flutter and left ventricular dysfunction: comparison of the ultra-short-acting beta1-selective blocker landiolol with digoxin (J-Land Study)","volume":"77","author":"Nagai","year":"2013","journal-title":"Circ J"},{"key":"2022061314501947100_suac024-B15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12325-014-0111-2","article-title":"Impacts of patient characteristics on the effectiveness of landiolol in AF\/AFL patients complicated with LV dysfunction: subgroup analysis of the J-Land study","volume":"31","author":"Kinugawa","year":"2014","journal-title":"Adv Ther"},{"key":"2022061314501947100_suac024-B16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.joa.2015.09.002","article-title":"Practical applicability of landiolol, an ultra-short-acting beta1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction","volume":"32","author":"Wada","year":"2016","journal-title":"J Arrhythm"},{"key":"2022061314501947100_suac024-B17","first-page":"1319","article-title":"Urgent control of rapid atrial fibrillation using landiolol in patients with acute decompensated heart failure with reduced or preserved left ventricular ejection fraction","volume":"37","author":"Ozaki TY","year":"2016","journal-title":"Eur Heart J"},{"key":"2022061314501947100_suac024-B18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.14740\/jocmr2954w","article-title":"Efficacy of intravenous administration of landiolol in patients with acute heart failure and supraventricular tachyarrhythmia","volume":"9","author":"Kiuchi","year":"2017","journal-title":"J Clin Med Res"},{"key":"2022061314501947100_suac024-B19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1253\/circj.CJ-18-1131","article-title":"Differential effectiveness of landiolol between atrial fibrillation and atrial flutter\/atrial tachycardia patients with left ventricular dysfunction","volume":"83","author":"Oka","year":"2019","journal-title":"Circ J"},{"key":"2022061314501947100_suac024-B20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1253\/circrep.CR-19-0076","article-title":"Urgent control of rapid atrial fibrillation by landiolol in patients with acute decompensated heart failure with severely reduced ejection fraction","volume":"1","author":"Iwahashi","year":"2019","journal-title":"Circ Rep"},{"key":"2022061314501947100_suac024-B21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40801-019-0149-1","article-title":"Effects of intravenous landiolol on heart rate and outcomes in patients with atrial tachyarrhythmias and acute decompensated heart failure: a single-center experience","volume":"6","author":"Matsui","year":"2019","journal-title":"Drugs Real World Outcomes"},{"key":"2022061314501947100_suac024-B22","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1536\/ihj.20-256","article-title":"Comparison of landiolol and digoxin as an intravenous drug for controlling the heart rate in patients with atrial fibrillation and severely depressed left ventricular function","volume":"61","author":"Shinohara","year":"2020","journal-title":"Int Heart J"},{"key":"2022061314501947100_suac024-B23","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock \u2013 a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Chioncel","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022061314501947100_suac024-B24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/2048872619894255","article-title":"Atrial fibrillation in acute heart failure: a position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology","volume":"9","author":"Gorenek","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2022061314501947100_suac024-B25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/europace\/euy310","article-title":"Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis","volume":"21","author":"Um","year":"2019","journal-title":"Europace"},{"key":"2022061314501947100_suac024-B26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(16)31258-2","article-title":"Rate control in atrial fibrillation","volume":"388","author":"Van Gelder","year":"2016","journal-title":"Lancet"},{"key":"2022061314501947100_suac024-B27","first-page":"3250","article-title":"Atrial fibrillation in heart failure: what should we do?","volume":"36","author":"Kotecha","year":"2015","journal-title":"Eur Heart J"},{"key":"2022061314501947100_suac024-B28","doi-asserted-by":"crossref","first-page":"h4451","DOI":"10.1136\/bmj.h4451","article-title":"Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data [published correction appears in BMJ. 2015; 351:h4937]","volume":"351","author":"Ziff","year":"2015","journal-title":"BMJ"},{"key":"2022061314501947100_suac024-B29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2005.06.048","article-title":"Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate","volume":"110","author":"Hofmann","year":"2006","journal-title":"Int J Cardiol"},{"key":"2022061314501947100_suac024-B30","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/eurheartj\/ehz837","article-title":"The 2019 ESC guidelines for the management of patients with supraventricular tachycardia","volume":"40","author":"Calkins","year":"2019","journal-title":"Eur Heart J"},{"key":"2022061314501947100_suac024-B31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.CIR.0000021113.44111.3E","article-title":"Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis","volume":"106","author":"Crystal","year":"2002","journal-title":"Circulation"},{"key":"2022061314501947100_suac024-B32","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/eurheartj\/14.10.1375","article-title":"The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure. A study on diastolic function, heart rate and myocardial metabolism following intravenous metoprolol","volume":"14","author":"Andersson","year":"1993","journal-title":"Eur Heart J"},{"key":"2022061314501947100_suac024-B33","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1253\/circj.CJ-12-0033","article-title":"Low-dose \u03b2-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure","volume":"76","author":"Kobayashi","year":"2012","journal-title":"Circ J"},{"key":"2022061314501947100_suac024-B34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000355312","article-title":"A low-dose \u03b21-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation","volume":"127","author":"Kobayashi","year":"2014","journal-title":"Cardiology"},{"key":"2022061314501947100_suac024-B35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000499400","article-title":"Addition of a \u03b21-blocker to milrinone treatment improves cardiac function in patients with acute heart failure and rapid atrial fibrillation","volume":"142","author":"Kobayashi","year":"2019","journal-title":"Cardiology"},{"key":"2022061314501947100_suac024-B36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00380-013-0377-3","article-title":"Novel use of the ultra-short-acting intravenous \u03b21-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure","volume":"29","author":"Adachi","year":"2014","journal-title":"Heart Vessels"},{"key":"2022061314501947100_suac024-B37","doi-asserted-by":"crossref","first-page":"ehx502.P2699","DOI":"10.1093\/eurheartj\/ehx502.P2699","article-title":"Concomitant administration of landiolol and dobutamine in acute heart failure syndrome with atrial tachyarrhythmia","volume":"38","author":"Yoshima","year":"2017","journal-title":"Eur Heart J"},{"key":"2022061314501947100_suac024-B38","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","article-title":"Efficacy and safety of landiolol, an ultra-short-acting \u03b21-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial","volume":"8","author":"Kakihana","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2022061314501947100_suac024-B39","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1536\/ihj.15-103","article-title":"An experience of landiolol use for an advanced heart failure patient with severe hypotension","volume":"56","author":"Nitta","year":"2015","journal-title":"Int Heart J"},{"key":"2022061314501947100_suac024-B40","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1536\/ihj.19-420","article-title":"Successful combination of landiolol and levosimendan in patients with decompensated heart failure","volume":"61","author":"Dabrowski","year":"2020","journal-title":"Int Heart J"},{"key":"2022061314501947100_suac024-B41","doi-asserted-by":"crossref","first-page":"bcr2017222268","DOI":"10.1136\/bcr-2017-222268","article-title":"Landiolol is effective for the treatment of tachycardia-induced cardiogenic shock in patients during septic shock therapy","volume":"2017","author":"Arita","year":"2017","journal-title":"BMJ Case Rep"},{"key":"2022061314501947100_suac024-B42","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/CIRCRESAHA.114.300568","article-title":"Role of RyR2 phosphorylation in heart failure and arrhythmias: controversies around ryanodine receptor phosphorylation in cardiac disease","volume":"114","author":"Dobrev","year":"2014","journal-title":"Circ Res"},{"key":"2022061314501947100_suac024-B43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI62834","article-title":"Calcium cycling proteins and heart failure: mechanisms and therapeutics","volume":"123","author":"Marks","year":"2013","journal-title":"J Clin Invest"},{"key":"2022061314501947100_suac024-B44","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/cvr\/cvq324","article-title":"The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications","volume":"89","author":"Dobrev","year":"2011","journal-title":"Cardiovasc Res"},{"key":"2022061314501947100_suac024-B45","doi-asserted-by":"crossref","first-page":"e0114314","DOI":"10.1371\/journal.pone.0114314","article-title":"A low-dose \u03b21-blocker in combination with milrinone improves intracellular Ca2\u2009+\u2009handling in failing cardiomyocytes by inhibition of milrinone-induced diastolic Ca2\u2009+\u2009leakage from the sarcoplasmic reticulum","volume":"10","author":"Kobayashi","year":"2015","journal-title":"PLoS One"},{"key":"2022061314501947100_suac024-B46","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.cjca.2021.08.018","article-title":"Adverse events associated with electrical cardioversion in patients with acute atrial fibrillation and atrial flutter [published online ahead of print, 2021 Aug 30]","volume":"37","author":"Stiell","year":"2021","journal-title":"Can J Cardiol"},{"key":"2022061314501947100_suac024-B47","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/europace\/eut106","article-title":"Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study","volume":"15","author":"Gr\u00f6nberg","year":"2013","journal-title":"Europace"},{"key":"2022061314501947100_suac024-B48","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1097\/CCM.0b013e3181709e43","article-title":"Treatment of new-onset atrial fibrillation in noncardiac intensive care unit patients: a systematic review of randomized controlled trials","volume":"36","author":"Kanji","year":"2008","journal-title":"Crit Care Med"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/24\/Supplement_D\/D22\/44045043\/suac024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/24\/Supplement_D\/D22\/44045043\/suac024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T14:53:25Z","timestamp":1655132005000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/24\/Supplement_D\/D22\/6607628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":48,"journal-issue":{"issue":"Supplement_D","published-online":{"date-parts":[[2022,6,13]]},"published-print":{"date-parts":[[2022,6,13]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suac024","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2022,6,1]]}}}